Novo Holdings completes $16.5 bln takeover of Catalent

Reuters

2024/12/18

Novo Holdings completes $16.5 bln takeover of <a href="https://laohu8.com/S/CTLT">Catalent</a>

Dec 18 (Reuters) - Novo Holdings has completed its $16.5 billion takeover of Catalent CTLT.N, the contract drug manufacturer announced on Wednesday, days after the companies said all regulatory closing conditions were fulfilled.

Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk NOVOb.CO, which makes the blockbuster GLP-1 injectable weight-loss drug Wegovy.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Maju Samuel)

((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2492186252"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492186252\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2492186252?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-18 22:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492186252","market":"us","top_or_hot":-1,"title":"Novo Holdings completes $16.5 bln takeover of Catalent","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Novo Holdings completes $16.5 bln takeover of <a href=\"https://laohu8.com/S/CTLT\">Catalent</a> </title></head><body><p><span>Dec 18 (Reuters)</span><span> - </span>Novo Holdings has completed its $16.5 billion takeover of Catalent <span>CTLT.N</span>, the contract drug manufacturer announced on Wednesday, days after the companies said all regulatory closing conditions were fulfilled. </p><p>Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk <span>NOVOb<a href=\"https://laohu8.com/S/02403\">.C</a>O</span>, which makes the blockbuster GLP-1 injectable weight-loss drug Wegovy.</p><p> (Reporting by Bhanvi Satija in Bengaluru; Editing by Maju Samuel)</p><p> ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Holdings completes $16.5 bln takeover of Catalent</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Holdings completes $16.5 bln takeover of Catalent\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-12-18 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Novo Holdings completes $16.5 bln takeover of <a href=\"https://laohu8.com/S/CTLT\">Catalent</a> </title></head><body><p><span>Dec 18 (Reuters)</span><span> - </span>Novo Holdings has completed its $16.5 billion takeover of Catalent <span>CTLT.N</span>, the contract drug manufacturer announced on Wednesday, days after the companies said all regulatory closing conditions were fulfilled. </p><p>Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk <span>NOVOb<a href=\"https://laohu8.com/S/02403\">.C</a>O</span>, which makes the blockbuster GLP-1 injectable weight-loss drug Wegovy.</p><p> (Reporting by Bhanvi Satija in Bengaluru; Editing by Maju Samuel)</p><p> ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4530","symbol_name":"医药外包概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4N3NJ10C:1","article_id":"2492186252","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492186252","pubTimestamp":1734530693,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Novo Holdings completes $16.5 bln takeover of Catalent Dec 18  - Novo Holdings has completed its $16.5 billion takeover of Catalent CTLT.N, the contract drug manufacturer announced on Wednesday, days after the companies said all regulatory closing conditions were fulfilled. Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk NOVOb.CO, which makes the blockbuster GLP-1 injectable weight-loss drug Wegovy.  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4530":"医药外包概念","BK4007":"制药","BK4588":"碎股","CTLT":"Catalent","BK4585":"ETF&股票定投概念"},"translate_title":"Novo Holdings完成165亿美元收购Catalent","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTLT":0.9},"content_text":"Novo Holdings completes $16.5 bln takeover of Catalent Dec 18 (Reuters) - Novo Holdings has completed its $16.5 billion takeover of Catalent CTLT.N, the contract drug manufacturer announced on Wednesday, days after the companies said all regulatory closing conditions were fulfilled. Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk NOVOb.CO, which makes the blockbuster GLP-1 injectable weight-loss drug Wegovy. (Reporting by Bhanvi Satija in Bengaluru; Editing by Maju Samuel) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"shareholding,corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}